Bowhead Specialty (BOW) Competitors $30.95 -0.79 (-2.49%) As of 01:16 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock BOW vs. BWIN, HGTY, GSHD, PLMR, NMIH, ALHC, CS, BHF, HG, and SPNTShould you be buying Bowhead Specialty stock or one of its competitors? The main competitors of Bowhead Specialty include Baldwin Insurance Group (BWIN), Hagerty (HGTY), Goosehead Insurance (GSHD), Palomar (PLMR), NMI (NMIH), Alignment Healthcare (ALHC), Credit Suisse Group (CS), Brighthouse Financial (BHF), Hamilton Insurance Group (HG), and SiriusPoint (SPNT). These companies are all part of the "insurance" industry. Bowhead Specialty vs. Its Competitors Baldwin Insurance Group Hagerty Goosehead Insurance Palomar NMI Alignment Healthcare Credit Suisse Group Brighthouse Financial Hamilton Insurance Group SiriusPoint Baldwin Insurance Group (NASDAQ:BWIN) and Bowhead Specialty (NYSE:BOW) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, dividends, earnings, media sentiment, profitability, analyst recommendations, institutional ownership and valuation. Do analysts prefer BWIN or BOW? Baldwin Insurance Group presently has a consensus price target of $43.67, suggesting a potential upside of 29.57%. Bowhead Specialty has a consensus price target of $38.33, suggesting a potential upside of 23.86%. Given Baldwin Insurance Group's higher probable upside, equities analysts plainly believe Baldwin Insurance Group is more favorable than Bowhead Specialty.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Baldwin Insurance Group 2 Sell rating(s) 2 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.25Bowhead Specialty 0 Sell rating(s) 3 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.63 Does the media refer more to BWIN or BOW? In the previous week, Bowhead Specialty had 2 more articles in the media than Baldwin Insurance Group. MarketBeat recorded 9 mentions for Bowhead Specialty and 7 mentions for Baldwin Insurance Group. Baldwin Insurance Group's average media sentiment score of 1.44 beat Bowhead Specialty's score of 0.16 indicating that Baldwin Insurance Group is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baldwin Insurance Group 6 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Bowhead Specialty 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral Which has more volatility & risk, BWIN or BOW? Baldwin Insurance Group has a beta of 1.66, suggesting that its stock price is 66% more volatile than the S&P 500. Comparatively, Bowhead Specialty has a beta of -0.69, suggesting that its stock price is 169% less volatile than the S&P 500. Do institutionals & insiders hold more shares of BWIN or BOW? 77.5% of Baldwin Insurance Group shares are owned by institutional investors. 20.1% of Baldwin Insurance Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Is BWIN or BOW more profitable? Bowhead Specialty has a net margin of 10.05% compared to Baldwin Insurance Group's net margin of -1.22%. Bowhead Specialty's return on equity of 13.25% beat Baldwin Insurance Group's return on equity.Company Net Margins Return on Equity Return on Assets Baldwin Insurance Group-1.22% 13.24% 3.82% Bowhead Specialty 10.05%13.25%2.94% Which has stronger earnings and valuation, BWIN or BOW? Bowhead Specialty has lower revenue, but higher earnings than Baldwin Insurance Group. Baldwin Insurance Group is trading at a lower price-to-earnings ratio than Bowhead Specialty, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBaldwin Insurance Group$1.39B2.88-$24.52M-$0.29-116.21Bowhead Specialty$425.66M2.38$38.24M$1.4721.05 SummaryBaldwin Insurance Group and Bowhead Specialty tied by winning 8 of the 16 factors compared between the two stocks. Get Bowhead Specialty News Delivered to You Automatically Sign up to receive the latest news and ratings for BOW and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BOW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BOW vs. The Competition Export to ExcelMetricBowhead SpecialtyINS IndustryFinance SectorNYSE ExchangeMarket Cap$1.01B$57.52B$12.46B$21.15BDividend YieldN/A1.86%5.47%3.55%P/E Ratio21.0516.3519.3628.97Price / Sales2.382.7627.1253.05Price / Cash24.0828.7819.1818.23Price / Book2.732.982.284.70Net Income$38.24M$4.66B$1.01B$995.89M7 Day Performance2.35%1.87%1.68%2.18%1 Month Performance-6.07%1.95%1.50%1.98%1 Year Performance-0.10%16.64%541.77%10.48% Bowhead Specialty Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BOWBowhead Specialty2.3742 of 5 stars$30.95-2.5%$38.33+23.9%+2.5%$1.01B$425.66M21.05193BWINBaldwin Insurance Group4.084 of 5 stars$32.69-0.5%$43.67+33.6%-24.5%$3.90B$1.39B-112.724,116News CoveragePositive NewsHGTYHagerty1.7068 of 5 stars$11.00-1.7%$10.00-9.1%-6.2%$3.83B$1.20B54.981,744GSHDGoosehead Insurance3.9626 of 5 stars$85.29-0.9%$110.91+30.0%+11.4%$3.23B$314.51M75.481,580PLMRPalomar4.3237 of 5 stars$120.53+0.2%$165.83+37.6%+26.3%$3.22B$553.86M21.18150Positive NewsNMIHNMI2.3568 of 5 stars$38.67-0.8%$42.33+9.5%+1.4%$3.02B$679.62M8.21234Positive NewsALHCAlignment Healthcare1.676 of 5 stars$15.29+1.6%$18.56+21.4%+70.9%$2.98B$2.70B-54.611,679Analyst UpgradeInsider TradeCSCredit Suisse GroupN/A$0.89flatN/AN/A$2.77B$22.88B1.3750,480BHFBrighthouse Financial4.9239 of 5 stars$45.59-0.2%$59.67+30.9%+3.8%$2.61B$6.15B4.931,400Positive NewsHGHamilton Insurance Group2.6327 of 5 stars$23.03-1.4%$25.43+10.4%+22.5%$2.34B$2.33B6.36550SPNTSiriusPoint3.6393 of 5 stars$18.21-0.4%$25.00+37.3%+25.0%$2.13B$2.60B20.461,072Positive News Related Companies and Tools Related Companies Baldwin Insurance Group Alternatives Hagerty Alternatives Goosehead Insurance Alternatives Palomar Alternatives NMI Alternatives Alignment Healthcare Alternatives Credit Suisse Group Alternatives Brighthouse Financial Alternatives Hamilton Insurance Group Alternatives SiriusPoint Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BOW) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bowhead Specialty Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bowhead Specialty With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.